1214O Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO)
2020
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
17
Citations
NaN
KQI